Epigenetics is the study of the control mechanisms that sit on top of genes and guide the function and fate of individual cells. The field is expected to radically change traditional approaches to many healthcare areas, including cancer therapeutics and tissue regeneration.

Status current

Associated Fund UK Innovation & Science Seed Fund

Sector Medical / Biotechnology


Associated Team Members

Relevant News

CellCentric Gains £4.3m To Take Prostate Cancer Programme Through To Clinical Candidates

25 June 2013 New investment coupled with a major award from the UK’s innovation agency,…

read more

CellCentric enters clinic with first-in-class p300/CBP inhibitor for late-stage prostate...

CellCentric is a biotechnology company focused on a first-in-class p300/CBP bromodomain inhibitor drug, CCS1477....

read more

CellCentric raises $26 million to take first-in-class p300/CBP inhibitor into...

Cambridge, UK; May 15, 2018: CellCentric Ltd (CellCentric) has raised $26 million in private...

read more

More Companies in Medical / Biotechnology

Your browser is out-of-date!

Update your browser to view this website correctly.Update my browser now